Author

Sabrina Gloria Giulia Testoni

IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH THE HYBRIDTHERM PROBE IN LOCALLY ADVANCED AND BORDERLINE RESECTABLE PANCREATIC CANCER: RESULTS FROM A PHASE II RANDOMIZED CONTROLLED TRIAL
IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH THE HYBRIDTHERM PROBE IN LOCALLY ADVANCED AND BORDERLINE RESECTABLE PANCREATIC CANCER: RESULTS FROM A PHASE II RANDOMIZED CONTROLLED TRIAL

G-POEM FOR REFRACTORY GASTROPARESIS: BASAL SYMPTOM SEVERITY AND INTRAGASTRIC MEAL DISTRIBUTION DURING GASTRIC EMPTYING SCINTIGRAPHY MAY BE PREDICTORS OF 12-MONTH CLINICAL OUTCOME
G-POEM FOR REFRACTORY GASTROPARESIS: BASAL SYMPTOM SEVERITY AND INTRAGASTRIC MEAL DISTRIBUTION DURING GASTRIC EMPTYING SCINTIGRAPHY MAY BE PREDICTORS OF 12-MONTH CLINICAL OUTCOME

Sabrina Gloria Giulia Testoni  et al.

IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH THE HYBRIDTHERM PROBE IN LOCALLY ADVANCED AND BORDERLINE RESECTABLE PANCREATIC CANCER: RESULTS FROM A PHASE II RANDOMIZED CONTROLLED TRIAL
IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH THE HYBRIDTHERM PROBE IN LOCALLY ADVANCED AND BORDERLINE RESECTABLE PANCREATIC CANCER: RESULTS FROM A PHASE II RANDOMIZED CONTROLLED TRIAL

Sabrina Gloria Giulia Testoni  et al.

FEASIBILITY AND OPTIMIZATION OF RNA EXTRACTION FROM EUS-ACQUIRED TISSUE IN PANCREATIC CANCER
FEASIBILITY AND OPTIMIZATION OF RNA EXTRACTION FROM EUS-ACQUIRED TISSUE IN PANCREATIC CANCER

Sabrina Gloria Giulia Testoni  et al.

RNA-SEQUENCING OF PANCREATIC CANCER FROM EUS-ACQUIRED TISSUE IS USEFUL TO DEFINE MOLECULAR SUBTYPES AND PROGNOSIS
RNA-SEQUENCING OF PANCREATIC CANCER FROM EUS-ACQUIRED TISSUE IS USEFUL TO DEFINE MOLECULAR SUBTYPES AND PROGNOSIS

Sabrina Gloria Giulia Testoni  et al.

STANDARDIZATION OF A RADIOFREQUENCY ABLATION SYSTEM WITH EX-VIVO PANCREATIC ADENOCARCINOMA ABLATION
STANDARDIZATION OF A RADIOFREQUENCY ABLATION SYSTEM WITH EX-VIVO PANCREATIC ADENOCARCINOMA ABLATION

Sabrina Gloria Giulia Testoni  et al.

Item 1 - 6 / 6
1